PureTech Health plc (NASDAQ:PRTC – Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $25.48, but opened at $26.94. PureTech Health shares last traded at $26.94, with a volume of 315 shares changing hands.
PureTech Health Price Performance
The business’s 50-day simple moving average is $26.29 and its two-hundred day simple moving average is $23.45.
Institutional Trading of PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. Jane Street Group LLC acquired a new position in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 8,343 shares of the company’s stock, valued at approximately $269,000. Institutional investors and hedge funds own 0.04% of the company’s stock.
About PureTech Health
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Featured Articles
- Five stocks we like better than PureTech Health
- How to Invest in Insurance Companies: A Guide
- Comprehensive Analysis of PayPal Stock
- How to buy stock: A step-by-step guide for beginners
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What is Short Interest? How to Use It
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
